Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel

被引：0

作者：

Brandao, M. ^{[1
]}

Prisciandaro, E. ^{[2
]}

Xenophontos, E. ^{[3
]}

Mariolo, A. ^{[4
]}

Sadeghi, A. H. ^{[5
]}

Filippi, A. R. ^{[6
]}

Levy, A. ^{[7
]}

Bandura, A. ^{[8
]}

Caramella, C. ^{[9
]}

Dickhoff, C. ^{[10
]}

de Margerie-Mellon, C. ^{[11
]}

Faivre-Finn, C. ^{[12
]}

Portik, D. ^{[3
]}

Sanchez-Lorente, D. ^{[13
]}

De Ruysscher, D. ^{[14
]}

Smit, E. ^{[15
]}

Gobbini, E. ^{[16
]}

Fadel, E. ^{[17
]}

Ruffini, E. ^{[18
]}

Olmetto, E. ^{[19
]}

Cortiula, F. ^{[20
]}

Bahce, I. ^{[10
]}

Houda, I.

Opitz, I. ^{[21
]}

Naidoo, J. ^{[22
]}

Edwards, J. ^{[23
]}

Remon, J. ^{[7
]}

Benitez, J. C. ^{[24
]}

Trujillo, J. C. ^{[25
]}

Derks, J. ^{[26
]}

Amrane, K. ^{[27
]}

Hartemink, K. ^{[28
]}

Stathopoulos, K. ^{[1
]}

Hendriks, L.

Iglesias, M. ^{[29
]}

Occhipinti, M. ^{[30
]}

Guckenberger, M. ^{[21
]}

Levra, N. Giaj ^{[31
]}

Girard, N. ^{[16
]}

Reguart, N.

Mercier, O.

Bironzo, P. ^{[32
]}

Hofman, P. ^{[33
]}

Petersen, R. Horsleben ^{[34
]}

De Angelis, R.

Abgral, R. ^{[35
]}

Terrisse, S. ^{[36
]}

Popat, S. ^{[37
]}

Pierret, T. ^{[38
]}

Blum, T. Gerriet ^{[39
]}

机构：

[1] Univ Bruxelles, Inst Jules Bordet Hop, Brussels, Belgium

[2] UZ Leuven Campus Gasthuisberg, Leuven, Belgium

[3] EORTC, Brussels, Belgium

[4] Inst Thorax Curie Montsouris, Inst Mutualiste Montsouris IMM, Paris, France

[5] Erasmus Univ, Med Ctr, Rotterdam, Netherlands

[6] Fdn IRCCS Policlin San Matteo Univ Pavi, Pavia, Italy

[7] Gustave Roussy, Paris, France

[8] Med Univ Gdansk, Gdansk, Poland

[9] Hop Marie Lannelongue, Grp Hosp Paris St Joseph, Paris, France

[10] Amsterdam UMC, Canc Ctr Amsterdam, Amsterdam, Netherlands

[11] Hop St Louis, AP HP, Paris, France

[12] Christie NHS Fdn Trust, Manchester, Lancs, England

[13] Hosp Clin Barcelona, Barcelona, Spain

[14] Maastro Clin Maastricht Radiat Oncol, Maastricht, Netherlands

[15] Leiden Univ, Med Ctr, Leiden, Netherlands

[16] Inst Curie, Paris, France

[17] Univ Paris Sud, Hop Marie Lannelongue, Paris, France

[18] Univ Torino, Osped Molinette, Turin, Italy

[19] Azienda Osped Univ Careggi, Florence, Italy

[20] Azienda Osped Univ Santa Maria Misericordia Udine, Udine, Italy

[21] Univ Hosp Zurich, Zurich, Switzerland

[22] Beaumont Hosp, Dublin, Ireland

[23] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

[24] Hosp Univ Reg Virgen Victoria, Malaga & Biomed Res Inst Malaga IBIMA, Malaga, Spain

[25] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[26] Maastricht Univ, Med Ctr, Maastricht, Netherlands

[27] Ctr Hosp Pays Morlaix, Morlaix, France

[28] Antoni leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands

[29] Hosp Parc Tauli Sabadell, Barcelona, Spain

[30] IRCCS Fdn Ist Nazl Tumori, Milan, Italy

[31] IRCCS Osped Sacro Cuore Don Calabria, Verona, Italy

[32] Univ Torino Osped S Luigi Gonzaga, Turin, Italy

[33] CHU Nice, Hop Pasteur, Nice, France

[34] Copenhagen Univ Hosp, Rigshospitalet, Copenhagen, Denmark

[35] Univ Bretagne Occidentale, Brest, France

[36] Univ Paris Cite, Hop St Louis, AP HP Nord, Paris, France

[37] Royal Marsden Hosp Chelsea, London, England

[38] CHU Lyon, Hop Louis Pradel, Lyon, France

[39] HELIOS Klin, Berlin, Germany

[40] Univ Torino, Osped San Giovanni Battista, Turin, Italy

[41] Azienda Osped Univ Integrata Verona, Osped Borgo Trento, Verona, Italy

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

Resectable; Stage III; Non-small cell lung cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.28-09

引用

页码：S292 / S293

页数：2

共 50 条

[41] Radiochemotherapy in non-small cell lung cancer (NSCLC): A critical review
Gomez Caamano, Antonio
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 : S16 - S16
[42] Chemotherapy in resectable non-small cell lung cancer
Enriqueta Felip
Revista de Oncología, 2004, 6 (1): : 52 - 56
[43] Randomized Pan-European trial comparing paclitaxel (TAX)/carboplatin (CAR) versus paclitexel/cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC)
Gatzemeier, U
Rosell, R
Betticher, D
Keppler, U
Macha, HN
Pirker, R
Berthet, P
Breau, JL
Bogaerts, J
Gallant, G
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S246 - S246
[44] Hypoxic markers in non-small cell lung cancer (NSCLC) - A review
Xu, F. -X.
Zhang, Y. -L.
Liu, J. -J.
Zhang, D. -D.
Chen, H. -B.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (05) : 849 - 852
[45] A phase Ib trial of neoadjuvant chemoradiotherapy and durvalumab (MEDI4736) for potentially resectable stage III non-small cell lung cancer (NSCLC)
Ahn, B. C.
Lee, S.
Seo, J. W.
Lee, C. Y.
Lee, J. G.
Park, S. Y.
Kim, D. J.
Lee, C. G.
Cho, J.
Yoon, H. I.
Shim, B. Y.
Cho, D. G.
Kim, S. W.
Park, H. S.
Chun, Y. J.
Hong, M. H.
Kim, H. R.
Cho, B. C.
ANNALS OF ONCOLOGY, 2019, 30 : 601 - 601
[46] SPIROMETRY IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)
Mendis, R.
McDonald, C. F.
John, T.
O'Donoghue, F. J.
White, S. C.
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
[47] Proton therapy for stage I non-small cell lung cancer (NSCLC)
Nihei, K
Ogino, T
Ishikura, S
Nishimura, H
Kawashima, M
Arahira, S
Onozawa, M
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S282 - S282
[48] Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment-a narrative review
Calvo, Virginia
Aliaga, Carlos
Carracedo, Carlos
Provencio, Mariano
TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 581 - 589
[49] Rapid Advances in Resectable Non-Small Cell Lung Cancer: A Narrative Review
West, Howard
Kim, Jae Y.
JAMA ONCOLOGY, 2024, 10 (02) : 249 - 255
[50] Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Price, Katharine A. R.
Azzoli, Christopher G.
Gaspar, Laurie E.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 204 - 209

← 1 2 3 4 5 →